Lineage Cell Therapeutics

$LCTX’s @CEO_Culley is looking forward to joining Ben Beneski, SVP & CTO of @AllogeneTx, on the next live @_CellandGenewebinar, moderated by @Erin_Harris1 to discuss the requirements for #celltherapy late-stage development and commercialization. Register to watch on 11/12 here: event.on24.com/wcc/r/5524667… #CellTherapy #GeneTherapy #RegenerativeMedicine #ReplaceandRestore

$LCTX today provided an update on its ReSonanceTM (ANP1) program for #hearingloss. The program is built on our patented AlloSCOPETMmanufacturing platform, and is currently being developed under a research collaboration with William Demant Invest A/S (WDI). Learn more: investor.lineagecell.com/new… @CEO_Culley | #ReplaceAndRestore #CellTherapy #HearingLoss #RegenerativeMedicine @ca_navntoft

#CTS2026 replays are now available on demand. $LCTX’s @CEO_Culley was proud to sit alongside presenters from @AbbVie, Oculis, @Valitorbio, @NeurotechPharma, @RecenseM and others, as part of the “From Innovation to Approval: Bringing Novel Treatments to Market” panel, moderated by Pravin U. Dugel, M.D., of @OCUTX. Watch the recorded sessions: ctsretina.org/ #CTSRetina #ClinicalTrials #Ophthalmology #CellTherapy #ReplaceandRestore | @CEO_Culley @ArshadKhanani @CTS_Tahoe

Nice to see our partner highlighting RPE cell therapy. At #AAO2026, #retina specialists heard firsthand about treatments that can make a meaningful difference for #dryAMD patients. $LCTX #OpRegen #ReplaceandRestore @CEO_Culley

$LCTX wishes to thank everyone who participated in the Spinal Cord Injury Patient-Focused Drug Development Meeting, especially individuals living with #SCI and care partners who shared their experiences and perspectives. Several themes came through clearly, including how restoring any kind of function, even incremental improvements, can translate into meaningful changes in everyday activities, personal care and quality of life. @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Join us on September 29 for the @scipfdd Spinal Cord Injury Patient-Focused Drug Development Meeting — a free, virtual event where the SCI community will share their experiences and needs directly with the FDA. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Register now for the free, virtual @scipfdd SCI PFDD Meeting on Sept. 29! Participants will discuss daily life with SCI, experiences with treatments, and priorities for future research. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Lineage is proud to support the upcoming @scipfdd SCI Patient-Focused Drug Development (PFDD) Meeting on September 29! This free, virtual event brings the experiences of individuals with SCI directly to FDA and treatment developers. scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Today, $LCTX announced the issuance of a U.S. Patent covering the company’s proprietary AlloSCOPE™ 5D manufacturing platform. investor.lineagecell.com/new… #CellManufacturing #ReplaceAndRestore